Loading clinical trials...
Loading clinical trials...
Introduction: GLP-1 receptor agonists (aGLP1) act increasing pancreatic insulin secretion in response to the glucose, they reduce glucagon secretion and reduce appetite by acting in the central level...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jose Seijas Amigo
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss
NCT07590193 · Diabetes Mellitus, Type 2
NCT07653074 · Myopia, Quality of Life
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
Centro de Salud de Culleredo
Culleredo, A Coruña
Centro de Salud de Fene
Fene, A Coruña
Centro de Salud de Ribeira
Ribeira, A Coruña
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions